{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-13",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "43624-040",
      "generic_name": "Trastuzumab Emtansine drug product 100 mg",
      "labeler_name": "BSP Pharmaceuticals S.p.A.",
      "active_ingredients": [
        {
          "name": "TRASTUZUMAB EMTANSINE",
          "strength": "20 mg/mL"
        }
      ],
      "finished": false,
      "packaging": [
        {
          "package_ndc": "43624-040-01",
          "description": "3 TRAY in 1 BOX (43624-040-01)  / 143 VIAL in 1 TRAY / 5 mL in 1 VIAL",
          "marketing_start_date": "22-FEB-13"
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {},
      "marketing_category": "DRUG FOR FURTHER PROCESSING",
      "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
      "spl_id": "5116a324-a638-3563-e063-6394a90a6790",
      "product_type": "DRUG FOR FURTHER PROCESSING",
      "marketing_start_date": "20130222",
      "product_id": "43624-040_5116a324-a638-3563-e063-6394a90a6790",
      "brand_name_base": null
    }
  ]
}